Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

The interplay between antibiotic resistance and bacterial fitness/virulence has attracted the
interest of researchers for decades because of its therapeutic implications, since it is …

Infections caused by ceftolozane-tazobactam and ceftazidime-avibactam-resistant P.
aeruginosa infections are an emerging concern. We aimed to analyze the underlying …

Objectives Pseudomonas aeruginosa (P. aeruginosa) are ubiquitous opportunistic
pathogens that combine intrinsic and acquired multidrug resistance phenotypes. Due to …

Ceftazidime-avibactam (CZA) is the combination of a third-generation cephalosporin and a
new non-β-lactam β-lactamase inhibitor capable of inactivating class A, C, and some D β …

Carbapenem-resistant P. aeruginosa has become a major clinical problem due to limited
treatment options. However, studies assessing the trends in the molecular epidemiology and …

Pseudomonas aeruginosa (PA) is a leading nosocomial pathogen and has great versatility
due to a complex interplay between antimicrobial resistance and virulence factors. PA has …

Feces in livestock farms is a reservoir of antibiotic resistance genes (ARGs), which can
disseminate into surrounding soil and air, bringing risks to human health. In this study …

We describe a case of New Delhi metallo-β-lactamase 1–producing carbapenem-resistant
Pseudomonas aeruginosa (CRPA) in a transplant patient with multiple hospitalizations in …

Pseudomonas aeruginosa is a ubiquitous bacterium, successfully exploiting a variety of
environmental niches due to its remarkable metabolic versatility. The World Health …